PP Sfikakis

705 total citations
20 papers, 154 citations indexed

About

PP Sfikakis is a scholar working on Rheumatology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, PP Sfikakis has authored 20 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in PP Sfikakis's work include Spondyloarthritis Studies and Treatments (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). PP Sfikakis is often cited by papers focused on Spondyloarthritis Studies and Treatments (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). PP Sfikakis collaborates with scholars based in Greece, United Kingdom and United States. PP Sfikakis's co-authors include Alexios Iliopoulos, DD Mitsikostas, M. N. Manoussakis, Haralampos Μ. Moutsopoulos, Konstantinos Psathakis, Maria G. Tektonidou, Maria Konsta, Giorgos Bamias, George Vaiopoulos and P. Kaklamanis and has published in prestigious journals such as European Heart Journal, Journal of Hepatology and Annals of the Rheumatic Diseases.

In The Last Decade

PP Sfikakis

16 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
PP Sfikakis Greece 6 64 48 31 28 26 20 154
Fleur Cohen France 9 54 0.8× 29 0.6× 42 1.4× 49 1.8× 16 0.6× 15 211
Priyanka Debta India 8 32 0.5× 17 0.4× 45 1.5× 19 0.7× 35 1.3× 48 248
C Bachmeyer France 7 59 0.9× 17 0.4× 48 1.5× 53 1.9× 25 1.0× 22 191
Hanns‐Martin Lorenz Germany 9 74 1.2× 76 1.6× 27 0.9× 28 1.0× 26 1.0× 19 278
Lucrezia Verardi Italy 6 31 0.5× 30 0.6× 43 1.4× 31 1.1× 48 1.8× 15 167
G. Natalello Italy 7 37 0.6× 25 0.5× 32 1.0× 32 1.1× 57 2.2× 24 165
Yuebo Jin China 10 63 1.0× 69 1.4× 24 0.8× 22 0.8× 12 0.5× 42 234
Carolina Artusi Italy 7 65 1.0× 46 1.0× 12 0.4× 13 0.5× 20 0.8× 11 161
S. Rekik Tunisia 8 68 1.1× 34 0.7× 36 1.2× 14 0.5× 22 0.8× 47 212
Francisco Morandeira Spain 10 23 0.4× 53 1.1× 29 0.9× 75 2.7× 27 1.0× 29 241

Countries citing papers authored by PP Sfikakis

Since Specialization
Citations

This map shows the geographic impact of PP Sfikakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PP Sfikakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PP Sfikakis more than expected).

Fields of papers citing papers by PP Sfikakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PP Sfikakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PP Sfikakis. The network helps show where PP Sfikakis may publish in the future.

Co-authorship network of co-authors of PP Sfikakis

This figure shows the co-authorship network connecting the top 25 collaborators of PP Sfikakis. A scholar is included among the top collaborators of PP Sfikakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PP Sfikakis. PP Sfikakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kouvari, Matina, Thomas Tsiampalis, Fotios Barkas, et al.. (2024). Investigating the diverse role of ultra-processed foods on cardiometabolic multimorbidity: Highlights from the ATTICA prospective study (2002-2022). European Heart Journal. 45(Supplement_1).
2.
Kiltz, Uta, PP Sfikakis, Éric Lespessailles, et al.. (2022). POS1053 LONG-TERM RETENTION, EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: RESULTS FROM THE OBSERVATIONAL SERENA STUDY. Annals of the Rheumatic Diseases. 81. 846–847. 1 indexed citations
3.
Brunborg, Cathrine, L. Czirják, É. Hachulla, et al.. (2022). Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis from EUSTAR. 1100–1100. 1 indexed citations
4.
Fragoulis, G., Μαρία Παππά, Gerasimos Evangelatos, et al.. (2021). POS1073 AXIAL PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS. SAME OR DIFFERENT? A REAL-WORLD STUDY WITH EMPHASIS ON COMORBIDITIES. Annals of the Rheumatic Diseases. 80. 815–816. 3 indexed citations
5.
Smolen, Josef S, Paul Bergmans, Kurt de Vlam, et al.. (2018). AB0928 Ustekinumab and tnf inhibitors in psoriatic arthritis: first follow-up data from a routine care study in 8 european countries (PSABIO). Annals of the Rheumatic Diseases. 77. 1589–1590. 2 indexed citations
6.
Nezos, Adrianos, et al.. (2017). THU0028 Type i interferon signature in the peripheral blood and CXCL4 plasma levels in patients with systemic sclerosis. Annals of the Rheumatic Diseases. 76. 210–210. 1 indexed citations
7.
Panopoulos, Stylianos, et al.. (2017). SAT0361 Chest computed tomography as an alternative to high resolution manometry for the diagnosis of scleroderma esophagus. Annals of the Rheumatic Diseases. 76. 908–908. 1 indexed citations
8.
Karatzi, Kalliopi, et al.. (2016). Association of consumption of dairy products and meat with retinal vessel calibers in subjects at increased cardiovascular risk. Nutrition Metabolism and Cardiovascular Diseases. 26(8). 752–757. 6 indexed citations
9.
Konsta, Maria, et al.. (2012). Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis. Lara D. Veeken. 52(3). 448–451. 32 indexed citations
10.
Protogerou, Athanase D., et al.. (2012). AB0379 Subclinical atherosclerosis in the femoral arteries: similar prevalence in rheumatoid arthritis and diabetes mellitus in a case control study. Annals of the Rheumatic Diseases. 71. 659–659. 2 indexed citations
11.
Iliopoulos, Alexios, et al.. (2006). Tuberculosis and granuloma formation in patients receiving anti-TNF therapy.. PubMed. 10(5). 588–90. 29 indexed citations
12.
13.
Solomou, Elena E., PP Sfikakis, Paraskevi Kotsi, et al.. (2003). 13q Deletion in Chronic Lymphocytic Leukemia: Characterization of E4.5, a Novel Chromosome Condensation Regulator-like Guanine Nucleotide Exchange Factor. Leukemia & lymphoma. 44(9). 1579–1585. 6 indexed citations
14.
Sfikakis, PP, et al.. (1998). Headache in systemic lupus erythematosus: a controlled study. Lara D. Veeken. 37(3). 300–303. 49 indexed citations
15.
Vaiopoulos, George, et al.. (1997). Tuberculosis of the sacroiliac joint. European Spine Journal. 6(5). 330–331. 11 indexed citations
16.
Mavrikakis, Myron, et al.. (1996). Retinal toxicity in long-term hydroxychloroquine treatment. American Journal of Ophthalmology. 122(1). 145–145. 2 indexed citations
17.
Antoniadou, Anastasia, et al.. (1990). Alpha-interferon in chronic viral hepatitis (Preliminary results). Journal of Hepatology. 11. S177–S177. 1 indexed citations
18.
Mavrikakis, Myron, et al.. (1990). Gout and neurological abnormalities associated with cardiomyopathy in a young man.. Annals of the Rheumatic Diseases. 49(11). 942–943. 2 indexed citations
19.
Sfikakis, PP, et al.. (1977). [Proquazone in the treatment of osteoarthritis of the knee: a double-blind comparison with naproxen (author's transl)].. PubMed. 34(10). 730–4. 1 indexed citations
20.
Sfikakis, PP. (1970). Isoniazid and alcohol.. PubMed. 101(6). 991–991.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026